| Value | ₹1.21 Cr |
|---|
BSE filing, NSE: CERA. Summary written from the filing by ALFA Finder's alert engine.
Cera Sanitaryware Ltd: key numbers
- Share price
- ₹4,440.00
- Market cap
- ₹5,726 Cr
- Revenue (annual)
- ₹2,050 Cr
- Net profit (annual)
- ₹204.2 Cr
- P/E (TTM)
- 28.2×Sector 42.1×
- Promoter holding
- 54.41%+0.00% QoQ
- FII holding
- 15.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cera Sanitaryware Ltd
All →Cera Sanitaryware Board Meeting Date
Cera Sanitaryware scheduled a board meeting on 4 Nov 2026 to approve Q2/H1 results and re-appoint its CMD and an Independent Director. No financial figures or transaction values are disclosed in this intimation.
Cera Sanitaryware Other Announcement
Cera Sanitaryware filed a routine Regulation 74(5) certificate confirming the processing and listing of dematerialized shares for the quarter ended September 30, 2026.
Cera Sanitaryware Capital Structure Change
Cera Sanitaryware Employees Welfare Trust purchased 2,335 equity shares via market route for a total consideration of ₹1.30 Crore.
- Value
- ₹1.30 Cr
Cera Sanitaryware Credit Rating
Cera Sanitaryware Limited received reaffirmed credit ratings from CARE Ratings Limited for its bank facilities. The total facility amount under the rating action is ₹100 Crore.
- Value
- ₹100.0 Cr
Cera Sanitaryware Earnings Call Transcript: Key Takeaways
Cera Sanitaryware reports robust 19.5% revenue growth in Q1FY27, but EBITDA margins were severely dented by brass and gas cost spikes alongside one-time worker settlement provisions.
- Call
- Guides 19% growth
Cera Sanitaryware Results Update
Cera Sanitaryware reported Q1 FY27 revenue of Rs. 486 Crore, up 19.5% year-on-year. PAT stood at Rs. 45.3 Crore despite pressure from elevated input costs.
- Value
- ₹486.0 Cr
Other employee stock options announcements
All →Alivus Life Sciences Employee Stock Options
Alivus Life Sciences allotted 1,95,833 equity shares to an employee who exercised ESOP options under its 2021 scheme. Paid-up capital rises to Rs. 24.59 Crore.
Archean Chemical Industries Employee Stock Options
Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.
Intellect Design Arena Employee Stock Options
Intellect Design Arena granted 1,83,500 RSUs to 19 associates under its ISOP/RSU 2016 scheme. This ESOP grant carries no transaction value for the event.
- Execution
- Vesting over 1st to 5th year from grant
Edelweiss Financial Services Employee Stock Options
Edelweiss Financial Services allotted 4,42,792 equity shares under its employee stock incentive and appreciation rights plans. No consideration amount is stated, so no event value applies.
Raymond Realty Employee Stock Options
Raymond Realty allotted 1,04,211 equity shares to its ESOP Trust under the RRL ESOP Scheme 2025 following option exercises. Paid-up capital rose to Rs 66.68 Crore.
Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.